Table 4.

Changes in the lipid levels tween baseline and week 12 in the 2 roxadustat initial-dose groups

Variable	Standard-dose group			Low-dose group			P for trend
	Baseline	Week 12	P	Baseline	Week 12	P
Triglyceride	1.6 (1.3–2.1)	1.3 (1.1–2.2)	0.03	1.7 (1.2–2.8)	1.7 (1.2–3.4)	0.95	0.04
Total cholesterol	4.1 ± 0.8	3.6 ± 0.9	0.01	4.3 ± 1.0	4.0 ± 1.1	0.03	0.29
HDL	1.0 ± 0.3	0.9 ± 0.2	0.01	0.9 ± 0.3	0.8 ± 0.3	0.002	0.33
LDL	2.0 ± 0.5	2.0 ± 0.6	0.37	2.2 ± 0.7	2.0 ± 0.7	0.051	0.31

HDL, high density lipoprotein; LDL, low density lipoprotein.

P for trend compared the change trend between roxadustat initial-dose groups; p, compared between baseline and week 12.